Toll-like receptor 4 (TLR4)-mediated immunomodulation was proved important for antibacterial infection, which recognizes pathogen-associated molecular patterns (PAMPs), such as lipopolysaccharide (LPS) from Gram-negative bacteria, and subsequently activates both innate and adaptive immune cells in the host (38, 39). The gene discussed is TLR4; the disease is infection.